Resolution: standard / high
Figure 3.
Incremental cost per QALY versus ranibizumab price for 3 time horizons, assuming the
base-case scenario.
Hurley et al. Cost Effectiveness and Resource Allocation 2008 6:12 doi:10.1186/1478-7547-6-12
Download authors' original image
